SCHEMBL8041564

SCHEMBL8041564

CCOC(=O)c1cn(CC)c2cc(Cl)c(F)cc2c1=O

nearest known ligand 0.82

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.69
ALDH1A1 P00352 5/20 0.64
HPGD P15428 4/20 0.64
KDM4E B2RXH2 4/20 0.64
HSD17B10 Q99714 4/20 0.64
KMT2A Q03164 2/20 0.64
LMNA P02545 3/20 0.61
MAPT P10636 2/20 0.49
MEN1 O00255 1/20 0.49
THRB P10828 1/20 0.49
TDP1 Q9NUW8 1/20 0.48
DRD3 P35462 1/20 0.47
NPC1 O15118 1/20 0.47
BRD4 O60885 1/20 0.47
TSHR P16473 1/20 0.47
HTT P42858 1/20 0.47
CYP2J2 P51589 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
P2RX3 P56373 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29823822 1.00 POLB (0.69) POLBALDH1A1HPGDKDM4EHSD17B10
SCHEMBL7128071 0.90 KMT2A (0.76) POLBALDH1A1HPGDKDM4EHSD17B10
SCHEMBL28433719 0.90 POLB (0.58) POLBALDH1A1HPGDKDM4EHSD17B10
SCHEMBL11398510 0.90 KMT2A (0.60) POLBALDH1A1HPGDKDM4EHSD17B10
SCHEMBL11067835 0.90 KMT2A (0.60) POLBALDH1A1HPGDKDM4EHSD17B10
SCHEMBL10472032 0.89 POLB (0.55) POLBALDH1A1HPGDKDM4EHSD17B10
SCHEMBL28331881 0.89 POLB (0.56) POLBALDH1A1HPGDKDM4EHSD17B10
SCHEMBL17775892 0.89 KMT2A (0.62) POLBALDH1A1HPGDKDM4EHSD17B10
SCHEMBL541725 0.88 POLB (0.54) POLBALDH1A1HPGDKDM4EHSD17B10
SCHEMBL11401440 0.88 KMT2A (0.84) POLBALDH1A1HPGDKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115385856-A Method for synthesizing norfloxacin intermediate by one-pot method 常州大学 2022-11-25 CN claimed
CN-114853671-A Preparation method of norfloxacin impurity 深圳振强生物技术有限公司 2022-08-05 CN claimed
CN-104774178-A Preparation method of ethyl 7-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate UNIV ZHEJIANG SCIENCES 2015-07-15 CN claimed
JP-62294689-A None JP disclosed
CN-109225114-B Self-circulation tubular reaction device with efficient mixer and reaction method adopting self-circulation tubular reaction device 葛沁怡 2024-07-12 CN disclosed
CN-115385856-A Method for synthesizing norfloxacin intermediate by one-pot method 常州大学 2022-11-25 CN disclosed
CN-114853671-A Preparation method of norfloxacin impurity 深圳振强生物技术有限公司 2022-08-05 CN disclosed
CN-107406390-B Modulators of monocarboxylic acid transporters and uses thereof 奈吉治疗公司 2021-04-16 CN disclosed
EP-3221295-B1 MONOCARBOXYLATE TRANSPORT MODULATORS AND USES THEREOF NIROGY THERAPEUTICS INC (US) 2021-04-14 EP disclosed
EP-3221295-B1 MONOCARBOXYLATE TRANSPORT MODULATORS AND USES THEREOF NIROGY THERAPEUTICS INC (US) 2021-04-14 EP disclosed
US-10766863-B2 Monocarboxylate transport modulators and uses thereof NIROGYONE THERAPEUTICS, INC. (US) 2020-09-08 US disclosed
EP-0280241-A2 Platen roller CANON KABUSHIKI KAISHA (JP) 1988-08-31 EP disclosed
EP-0250535-A1 NORFLOXACIN INTERMEDIATE. CHINOIN GYOGYSZER ES VEGYESZET (HU) 1988-01-07 EP disclosed
EP-0249620-A1 PROCESS FOR THE PREPARATION OF QUINOLINE CARBOXYLIC ACIDS. CHINOIN GYOGYSZER ES VEGYESZET (HU) 1987-12-23 EP disclosed
JP-S62294689-A QUINOLINE-3-CARBOXYLIC ACID DERIVATIVE DAI ICHI SEIYAKU CO LTD 1987-12-22 JP disclosed
WO-1987003595-A1 NORFLOXACIN INTERMEDIATE Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. (HU) 1987-06-18 WO disclosed
WO-1987003587-A1 PROCESS FOR THE PREPARATION OF QUINOLINE CARBOXYLIC ACIDS Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. (HU) 1987-06-18 WO disclosed
CN-86103954-A Preparation has the method for quinolone carboxylic acid ester's class of anti-microbial activity 1987-01-28 CN disclosed
US-4472579-A REACTING A PIPERAZINE WITH A CHLORO QUINOLINECARBOXYLIC ACID ESTER, HYDROLYSIS KYORIN SEIYAKU KABUSHIKI KAISHA (JP) 1984-09-18 US disclosed
US-4292317-A BACTERICIDES FOR GRAM NEGATIVE AND -POSITIVE BACTERIA; ANIMAL GROWTH REGULATORS LABORATORIE ROGER BELLON (FR) 1981-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10766863-B2 Monocarboxylate transport modulators and uses thereof SLC16A1, SLC16A3, SLC16A7 POLB 4243/4885ALDH1A1 521/4885HPGD 693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.